US Patent 7960112 Gene methylation in cancer diagnosis
Patent 7960112 was granted and assigned to Orion Genomics on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+325 characters)
Article
Patent abstract
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of cancer.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07960112 Gene methylation in cancer diagnosis US Patent 7960112 Gene methylation in cancer diagnosis
Infobox
Patent Number
0796011200
Patent Number
796011200
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079601120
Date of Patent
June 14, 2011
0Patent Application Number
120248030
Date Filed
February 1, 2008
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079601120
Date of Patent
June 14, 2011
0Patent Application Number
120248030
Date Filed
February 1, 2008
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07960112 Gene methylation in cancer diagnosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07960112
Date of patent
June 14, 2011
Patent application number
12024803
Date Filed
February 1, 2008
Patent primary examiner
Find more entities like US Patent 7960112 Gene methylation in cancer diagnosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
